Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation

BACKGROUND: Hematopoietic stem cell transplantation is a curative treatment for several haematological malignancies. However, treatment related morbidity and mortality still is a limiting factor. Cyclophosphamide is widely used in condition regimens either in combination with other chemotherapy or w...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Serafi, Ibrahim, Abedi-Valugerdi, Manuchehr, Potácová, Zuzana, Afsharian, Parvaneh, Mattsson, Jonas, Moshfegh, Ali, Hassan, Moustapha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899295/
https://www.ncbi.nlm.nih.gov/pubmed/24466173
http://dx.doi.org/10.1371/journal.pone.0086619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899295/
https://www.ncbi.nlm.nih.gov/pubmed/24466173
http://dx.doi.org/10.1371/journal.pone.0086619

Ejemplares similares